Online Database of Chemicals from Around the World
Search |  Submit |  中文
Home >> Chemical Listing >> D >> 3,4-Dihydro-4-oxophthalazine-1-acetic acid

3,4-Dihydro-4-oxophthalazine-1-acetic acid
[CAS# 25947-11-9]

List of Suppliers
SynQuest Labs, Inc. USA Inquire  
+1 (386) 462-0788
info@synquestlabs.com
Chemical manufacturer
chemBlink standard supplier since 2011
Biosynth AG. Switzerland Inquire  
+41 (71) 858-2020
welcome@biosynth.ch
Chemical manufacturer
chemBlink standard supplier since 2014
Achemica Switzerland Inquire  
+41 (24) 466-2929
contact@achemica.com
Chemical manufacturer since 2010
Exclusive Chemistry Ltd. Russia Inquire  
+7 (903) 713-5556
info@exchemistry.com
Chemical manufacturer
Matrix Scientific Inc. USA Inquire  
+1 (803) 788-9494
sales@matrixscientific.com
Chemical manufacturer
Atlantic Research Chemicals Ltd. UK Inquire  
+44 (8707) 746-454
info@atlantic-chemicals.com
Chemical manufacturer
Complete supplier list of 3,4-Dihydro-4-oxophthalazine-1-acetic acid
Identification
Classification Chemical reagent >> Organic reagent >> Bicyclic compound
Name 3,4-Dihydro-4-oxophthalazine-1-acetic acid
Synonyms NSC 408027
Molecular Structure CAS # 25947-11-9, 3,4-Dihydro-4-oxophthalazine-1-acetic acid, NSC 408027
Molecular Formula C10H8N2O3
Molecular Weight 204.18
CAS Registry Number 25947-11-9
EC Number 842-449-2
Properties
Solubility Slightly soluble (3.1 g/L) (25 ºC), Calc.*
Density 1.48±0.1 g/cm3 (20 ºC 760 Torr), Calc.*
Melting point 179-181 ºC**
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2015 ACD/Labs)
** Sinay, Terry Gene, Jr.; EP 331314 A2 1989.
Safety Data
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Specific target organ toxicity - single exposureSTOT SE3H335
Skin irritationSkin Irrit.2H315
Eye irritationEye Irrit.2AH319
SDS Available
Market Analysis Reports
List of Reports Available for 3,4-Dihydro-4-oxophthalazine-1-acetic acid
Related Products
1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid ethyl ester  1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid methyl ester  N-[4-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)phenyl]glycine  N-[6,9-Dihydro-6-oxo-9-[[2-(1-oxopropoxy)-1-[(1-oxopropoxy)methyl]ethoxy]methyl]-1H-purin-2-yl]propanamide  1,6-Dihydro-6-oxo-2-[[(phenylmethoxy)carbonyl]amino]-9H-purine-9-acetic acid  [S-(Z)]-2-[4,5-Dihydro-5-oxo-4-(phenylmethylene)-2-oxazolyl]-1-pyrrolidinecarboxylic acid 1,1-dimethylethyl ester  1,2-Dihydro-2-oxo-N-[2-(phenylmethyl)phenyl]-4-quinolinecarboxamide  (3Z)-2,3-Dihydro-2-oxo-3-(phenyl-1-piperidinylmethylene)-1H-indole-6-carboxylic acid methyl ester  1,6-Dihydro-6-oxo-1-(phenyl-2,3,4,5,6-d5)-3-pyridinecarboxylic acid  2,5-Dihydro-5-oxo-3-phenyl-1,2,4-triazine-6-carboxylic acid ethyl ester  5-[(3,4-Dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzonitrile  1-[5-[(3,4-Dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]piperazine  N-(6,7-Dihydro-6-oxo-1H-purin-2-yl)-2-methylpropanamide  1-[2-[(2S)-3,6-Dihydro-6-oxo-2H-pyran-2-yl]ethyl]-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1H-pyrrole-3-carboxamide  1,2-Dihydro-2-oxo-3-pyrazinecarbonitrile  5,6-Dihydro-6-oxo-2-pyrazinecarboxylic acid  5,6-Dihydro-5-oxo-2-pyrazinecarboxylic acid  7,8-Dihydro-8-oxo-pyrazino[2,3-d]pyridazine-5-acetic acid 1,1-dimethylethyl ester  4,5-Dihydro-5-oxo-1H-pyrazole-3-carboxylic acid ethyl ester  4,5-Dihydro-5-oxo-1H-pyrazole-3-carboxylic acid methyl ester